- Confirmed Gorlin Syndrome with PTCH1 mutation
- Adults, age 18 or older
- History of at least 10 BCCs on the face within past 24 months
- Cannot have participated in another Gorlin syndrome clinical study in past 3 months
Palvella plans to begin enrolling for the CODY Study in late spring 2021. We anticipate that your participation will last approximately six months. To qualify for CODY, participants must meet certain criteria, including confirmed diagnosis of Gorlin syndrome with the PTCH1 mutation.
If travel is required, financial and logistical assistance will be provided. As we plan for the study, we are mindful of the impact of COVID-19 on the health of our participants and clinicians.
Deciding whether to participate in a clinical trial is a voluntary and personal decision. We encourage you to talk with your family about whether enrolling in any clinical trial is the right decision for you.
Multiple locations across USA (TBD)
Travel Assistance Available